South Texas Accelerated Research Therapeutics (START) /ID# 276268

San Antonio, Texas 78229

1 studies enrolling now · 1 studies all time

What they study most

Gastric/Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, High-Grade Serous Ovarian Cancer, Micro Satellite Stable Colorectal Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer, Triple Negative Breast Cancer

Studies at this site

• Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan — Recruiting now